Skip to main content
FDA OKs Bayer's Betaseron autoinjector, companion app

The FDA has given Bayer approval for the Betaconnect electronic autoinjector and its companion app, myBETAapp, for use in patients with multiple sclerosis. The autoinjector facilitates administration of Betaseron, while the app allows data access and sharing between patients and health care professionals because it connects with the autoinjector via Bluetooth technology.

Full Story: